ABIVAX SA (2X1.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:2X1 - FR0012333284 - Common Stock
108 EUR
+6 (+5.88%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | 110.00K | 0.00 | 1.00K | |||
| Gross Profit | N/A | N/A | -110.00K | 0.00 | -1.00K | |||
| Operating Expenses | 173.00M | 127.00M | 56.49M | 42.56M | 38.01M | |||
| Research and Development | 146.53M | 103.18M | 48.70M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 39.00M | 29.00M | 8.00M | 6.37M | 5.69M | |||
| Operating Income | -173.00M | -127.00M | -56.60M | -42.56M | -38.01M | |||
| Interest Income/Expense | -1.51M | -15.82M | -3.80M | -436.00K | -741.00K | |||
| Other Income/Expense | -1.75M | -4.54M | -100.00K | -2.69M | -1.58M | |||
| Non Recurring Items | 0.00 | 0.00 | -13.90M | 125.00K | 200.00K | |||
| Income Before Taxes | -176.00M | -148.00M | -74.40M | -45.56M | -40.13M | |||
| Income Tax | 0.00 | 0.00 | -4.50M | -4.20M | -2.58M | |||
| Net Income | -176.00M | -148.00M | -69.80M | -41.36M | -37.55M | |||
| EBITDA | -171.90M | -126.29M | -56.12M | -42.40M | -37.94M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.80 | -3.43 | -4.16 | -2.47 | -2.62 | |||
| Statistics | ||||||||
All data in EUR